- Home
- BRTX vs MTR Comparison
BRTX vs MTR Comparison
Compare BRTX & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- MTR
- Stock Information
- Founded
- BRTX 1997
- MTR 1979
- Country
- BRTX United States
- MTR United States
- Employees
- BRTX N/A
- MTR N/A
- Industry
- BRTX Managed Health Care
- MTR Oil & Gas Production
- Sector
- BRTX Health Care
- MTR Energy
- Exchange
- BRTX Nasdaq
- MTR Nasdaq
- Market Cap
- BRTX 11.3M
- MTR 11.8M
- IPO Year
- BRTX N/A
- MTR N/A
- Fundamental
- Price
- BRTX $1.46
- MTR $6.02
- Analyst Decision
- BRTX Strong Buy
- MTR
- Analyst Count
- BRTX 1
- MTR 0
- Target Price
- BRTX $18.00
- MTR N/A
- AVG Volume (30 Days)
- BRTX 34.6K
- MTR 9.2K
- Earning Date
- BRTX 11-12-2024
- MTR 01-01-0001
- Dividend Yield
- BRTX N/A
- MTR 4.56%
- EPS Growth
- BRTX N/A
- MTR N/A
- EPS
- BRTX N/A
- MTR 0.35
- Revenue
- BRTX $377,000.00
- MTR $966,169.00
- Revenue This Year
- BRTX $598.90
- MTR N/A
- Revenue Next Year
- BRTX $162.81
- MTR N/A
- P/E Ratio
- BRTX N/A
- MTR $17.89
- Revenue Growth
- BRTX 189.55
- MTR N/A
- 52 Week Low
- BRTX $1.03
- MTR $5.60
- 52 Week High
- BRTX $3.67
- MTR $18.92
- Technical
- Relative Strength Index (RSI)
- BRTX 39.02
- MTR 43.23
- Support Level
- BRTX $1.44
- MTR $5.90
- Resistance Level
- BRTX $1.78
- MTR $6.31
- Average True Range (ATR)
- BRTX 0.16
- MTR 0.27
- MACD
- BRTX -0.01
- MTR -0.01
- Stochastic Oscillator
- BRTX 24.93
- MTR 10.13
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.